Invention Grant
- Patent Title: Pharmaceutical combination comprising LSZ102 and alpelisib
-
Application No.: US16204471Application Date: 2018-11-29
-
Publication No.: US10695333B2Publication Date: 2020-06-30
- Inventor: Tinya Abrams , Larry Alexander Gaither
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent David K. Cheung
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61P35/00 ; A61K31/381 ; C07D409/06
Abstract:
The present invention relates to a pharmaceutical combination comprising LSZ102 and alpelisib; pharmaceutical compositions comprising the same; and methods of using such combinations and compositions in the treatment or prevention of conditions in which degradation of estrogen receptors combined with PI3K inhibition is beneficial in, for example, the treatment of cancers.
Public/Granted literature
- US20190167652A1 PHARMACEUTICAL COMBINATION COMPRISING LSZ102 AND ALPELISIB Public/Granted day:2019-06-06
Information query
IPC分类:
